RAPPRapport Therapeutics, Inc. Common Stock

$1B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$125M

Net Income

-$111M

EPS (Diluted)

$-2.86

Cash Flow

Operating Cash Flow

-$87M

Free Cash Flow

-$88M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$512M

Total Liabilities

$28M

Stockholders' Equity

$485M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$839,000	+100.0%
Operating Income	-$125M	-$83M	-50.6%
Net Income	-$111M	-$78M	-42.4%

RAPP FY 2025 Earnings — Rapport Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena